Yazan Ashouri

Jordanian #MD, JUST Alumni| Previous Postdoc Research at the UofA|Outcome Research| Arsenal FC🔴⚪️

[Yazan Ashouri @AshouriYazan]

Boss. Innovator. Mentor @oozaidat

[SVIN @svinsociety]

Looking for a quick knowledge boost?

Check out our latest SVINute, Developing Neurointerventional Devices with Dr. Sam Zaidat, for bite-sized learning designed to keep you sharp in vascular and interventional neurology: https://t.co/N0hLbRCck1

#SVIN #SVINute #StrokeCare #MedEd

[SVIN @svinsociety]

#ResearchTuesday From the ASSIST registry cohort, in patients with tandem lesions, MT + acute CAS vs MT alone had better 90d functional outcomes without an increase in rates of sICH #SkimwithSVIN @NeuroIRdoc @Mo_majali91 @DoctorGaldamez @SVINJournal

https://t.co/8ZkXDYoJzF

[Yazan Ashouri @AshouriYazan]

@ArsenalNews_Hub The amount of made up stuff here is outrageous

[Yazan Ashouri @AshouriYazan]

@ArsenalNews_Hub I don’t know how you make these up. Then we be surprised while other fans hate us

[Stephan A Mayer @stephanamayer]

For non-US centers, this is a very informative post-hoc analysis of the Annexa-I trial of andexanet alfa for Xa inhibitor associated #ICH.

Predictors of ICH growth:

1. Earlier onset-to-CT times
2. Larger ICH volume (<6 hrs from onset)
3. Elevated DBP

Higher ICH growth velocity (>11 ml/hr) was associated with a whopping 60% risk of hematoma growth, and showed the greatest effect size w/ Andexxa (NNT of 4, an absolute 25% risk reduction)

#CodeICH keeps rolling!

https://t.co/olg9D1eNXJ

[Stephan A Mayer @stephanamayer]

Every once in a while you read something in the scientific literature which is really interesting and compelling…

Jeff Saver at @UCLAHealth has done that with a very interesting argument to standardize what we mean by “large core infarction”

I love the following:

1. Single author viewpoint. We need more of this. The collective gang banger “too big to fail” publication with 100+ authors is tired. Nice to hear an original voice

2. Original ideas coming from deep expertise — Jeff has recognized a disconnect among myriad definitions of “large core” and wants to help progress in research. Standardized terminology makes sense.

3. The math wonkiness! He proposes 75 ml as the definition of large core. All of the other subdivisions are based on intervals of 25 or 50. Round numbers!

4. Jeff dismisses the ASPECT score a bit, claiming that it is too semi-qualitative. The scores are already driven by radiomics on RAPID or VIZ. ASPECTS is awesome, but we all know that it will soon be automated.

5. As neurointensivists — let’s figure out the core volume threshold for hemicraniectomy watch. Game on!

Unifying Terminology for Ischemic Core Size in Acute Stroke https://t.co/xex1lrILzu

[Yazan Ashouri @AshouriYazan]

@oozaidat @Mo_majali91 @NeuroIRdoc
Check out or subgroup analysis regarding tandem occlusion. These findings awaiting to be confirmed by @ThePICASSOTrial
Everybody should be a picassoan

[Stroke: Vascular and Interventional Neurology @SVINJournal]

A subgroup analysis of the ASSIST prospective registry in patients with anterior circulation tandem lesions demonstrated better functional outcome with no safety concerns in patients who underwent acute stenting. @oozaidat
https://t.co/I4VEOXEeWL

[Stroke: Vascular and Interventional Neurology @SVINJournal]

A subgroup analysis of the ASSIST prospective registry in patients with anterior circulation tandem lesions demonstrated better functional outcome with no safety concerns in patients who underwent acute stenting. @oozaidat
https://t.co/I4VEOXEeWL

[نايف الفضلي @NAIFALFADLI]

ارسنال هذا الموسم في البريميرليغ سجل 71 هدف .. 27 هدف من كرات ثابتة .

تشيلسي 2004-2005 في البريميرليغ سجل 72 هدف .. 25 هدف من كرات ثابتة .

تشيلسي 2005-2006 في البريميرليغ سجل 72 هدف .. 24 هدف من كرات ثابتة .

وفيه لقطات تحتاج تدقيق اكثر وبتخلي الرقم اعلى .

بس ارتيتا يعتمد على الكرات الثابتة ☹️

[Yazan Ashouri @AshouriYazan]

Great pleasure to have Dr. Savastano for the Dooner Legacy Annual Lecture about endovascular management for subdural hematoma at the 10th annual Mercy health Stroke and NeuroEmergency symposium.

Great presentation with groundbreaking work
@oozaidat @mercy_health

[Amit Chaudhari MD @NeuroIRdoc]

✨ Acute carotid stenting with mechanical thrombectomy is superior with no change in adverse events, prospective ASSIST registry

https://t.co/ytVVttg1JV

[Galaxy Therapeutics @GalaxyThera]

LINNC Paris 2026

Galaxy Therapeutics is looking forward to joining the neurointerventional community in Paris for LINNC 2026.

We look forward to connecting with physicians, collaborators, and partners during one of the leading educational meetings in neurointervention.

[Ajith J. Thomas, MD @DrAjithThomas]

Inflammation as a Key Driver for Chronic Subdural Hematomas | Stroke https://t.co/HI6gWFfVUF

[Yazan Ashouri @AshouriYazan]

Very strong and promising outcomes and soon to be reinforced with main SEAL-IT trial.
@oozaidat @GalaxyThera @JNIS_BMJ
Just SEAL IT @SealTrial

[Galaxy Therapeutics @GalaxyThera]

Pre-SEAL IT 12-month results are now published in @JNIS_BMJ

• 84.6% complete occlusion
• 92.3% adequate occlusion
• 61.5% complete occlusion at 24h
• 100% technical success
• 0% major safety events

https://t.co/pp9aGsCGo0

[Yazan Ashouri @AshouriYazan]

@SVINJournal @oozaidat @Mo_majali91 @NeuroIRdoc Can we update the graphic abstract because this is not the correct one @SVINJournal

[Yazan Ashouri @AshouriYazan]

Innovation is key in care of stroke patients @NeuroIRdoc @oozaidat @Mo_majali91

[Stroke: Vascular and Interventional Neurology @SVINJournal]

Paclitaxel Drug-Coated Balloon Angioplasty for Medically Refractory Intracranial Atherosclerotic Disease: A US Single-Center Experience With the AGENT Balloon

https://t.co/8caq7LSv3G

[Yazan Ashouri @AshouriYazan]

Viktor

[The People’s Champion 🇯🇲🇵🇰🏴󠁧󠁢󠁥󠁮󠁧󠁿 @troopzafc]

Saw a lot of clips on the Gyokeres failed pass on Saturday but no one wants to post this clip lol I wonder why…

[Yazan Ashouri @AshouriYazan]

@_Afcbanks Head to head

[Ajith J. Thomas, MD @DrAjithThomas]

Pathophysiology of chronic subdural hematoma—new insights - Misa Trieu, Ajith J. Thomas, 2026 https://t.co/FyLrfS59Ik
We’ve gained new insights into Chronic Subdural Hematoma (cSDH) over the last decade. It’s no longer just about the initial injury—it's a cycle of inflammation and VEGF-driven neovascularization. Our new paper synthesizes this shift.
Prediction: We will move from embolization to targeted molecular therapies.

[Yazan Ashouri @AshouriYazan]

@1Joux صحيح أنصاب ٢٥ مرة ولكن
الله يجبر خاطرنا بالمرينا فيه